Jiangsu Hengrui Medicine Co Ltd (600276) — Tangible Net Worth Ratio

Latest as of September 2025: 89.5%

Jiangsu Hengrui Medicine Co Ltd (600276) has a Tangible Net Worth Ratio of 89.5% as of September 2025. This metric is calculated by deducting intangible assets (CN¥6.27 Billion) from net assets (CN¥60.03 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Jiangsu Hengrui Medicine Co Ltd (600276) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Tangible NW Ratio

89.5%
Tangible equity / total equity

Net Assets (Equity)

CN¥60.03 Billion
CNY

Intangible Assets

CN¥6.27 Billion
Goodwill, patents, brand value

Total Assets

CN¥68.33 Billion
CNY

Jiangsu Hengrui Medicine Co Ltd Tangible Net Worth Ratio (1997–2024)

This chart shows how Jiangsu Hengrui Medicine Co Ltd's Tangible Net Worth Ratio has changed across 28 annual periods from 1997 to 2024. As of September 2025, the ratio stands at 89.5%, reflecting net assets of CN¥60.03 Billion with intangible assets of CN¥6.27 Billion CNY. See Jiangsu Hengrui Medicine Co Ltd (600276) liquidity interval to measure how many days the company can operate on defensive assets alone.

Annual Tangible Net Worth Ratio for Jiangsu Hengrui Medicine Co Ltd (1997–2024)

The table below presents the year-by-year Tangible Net Worth Ratio for Jiangsu Hengrui Medicine Co Ltd from 1997 to 2024, covering 28 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Jiangsu Hengrui Medicine Co Ltd market capitalisation.

Year Tangible NW Ratio Net Assets (CNY) Intangible Assets Total Assets Change (pp)
2024 89.1% CN¥46.09 Billion CN¥5.03 Billion CN¥50.14 Billion ▼ -2.7 pp
2023 91.8% CN¥41.03 Billion CN¥3.38 Billion CN¥43.78 Billion ▼ -2.5 pp
2022 94.3% CN¥38.41 Billion CN¥2.20 Billion CN¥42.36 Billion ▼ -3.8 pp
2021 98.0% CN¥35.57 Billion CN¥702.44 Million CN¥39.27 Billion ▼ -0.9 pp
2020 98.9% CN¥30.79 Billion CN¥341.25 Million CN¥34.73 Billion ▲ +0.3 pp
2019 98.6% CN¥24.94 Billion CN¥349.76 Million CN¥27.56 Billion ▼ 0.0 pp
2018 98.6% CN¥19.80 Billion CN¥272.68 Million CN¥22.36 Billion ▲ +0.4 pp
2017 98.2% CN¥15.94 Billion CN¥279.26 Million CN¥18.04 Billion ▲ +0.5 pp
2016 97.8% CN¥12.87 Billion CN¥284.72 Million CN¥14.33 Billion ▼ -0.3 pp
2015 98.1% CN¥10.36 Billion CN¥195.85 Million CN¥11.50 Billion ▲ +0.5 pp
2014 97.6% CN¥8.29 Billion CN¥199.88 Million CN¥9.09 Billion ▲ +0.6 pp
2013 97.0% CN¥6.66 Billion CN¥202.67 Million CN¥7.22 Billion ▼ -1.8 pp
2012 98.8% CN¥5.44 Billion CN¥66.90 Million CN¥5.89 Billion ▼ -0.1 pp
2011 98.8% CN¥4.38 Billion CN¥51.34 Million CN¥4.82 Billion ▲ +0.3 pp
2010 98.5% CN¥3.47 Billion CN¥52.34 Million CN¥3.90 Billion ▲ +0.4 pp
2009 98.1% CN¥2.67 Billion CN¥50.28 Million CN¥3.00 Billion ▼ -0.4 pp
2008 98.6% CN¥2.02 Billion CN¥29.23 Million CN¥2.25 Billion ▲ +0.4 pp
2007 98.2% CN¥1.63 Billion CN¥29.91 Million CN¥2.01 Billion ▲ +0.4 pp
2006 97.7% CN¥1.26 Billion CN¥28.67 Million CN¥1.46 Billion ▼ -2.3 pp
2005 100.0% CN¥1.11 Billion CN¥0.00 CN¥1.29 Billion ▲ +0.1 pp
2004 99.9% CN¥998.05 Million CN¥656.52K CN¥1.26 Billion ▲ +1.4 pp
2003 98.5% CN¥903.35 Million CN¥13.56 Million CN¥1.45 Billion ▲ +0.3 pp
2002 98.2% CN¥809.97 Million CN¥14.36 Million CN¥1.20 Billion ▼ -1.5 pp
2001 99.7% CN¥757.99 Million CN¥2.16 Million CN¥1.12 Billion ▼ -0.3 pp
2000 100.0% CN¥672.57 Million CN¥0.00 CN¥986.27 Million ▲ +0.0 pp
1999 100.0% CN¥162.54 Million CN¥0.00 CN¥463.71 Million ▲ +0.0 pp
1998 100.0% CN¥141.53 Million CN¥0.00 CN¥365.52 Million ▲ +3.8 pp
1997 96.2% CN¥95.54 Million CN¥3.62 Million CN¥288.92 Million
pp = percentage points